Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

Por Myers, Jonathan S, Vold, Steven, Zaman, Fiaz, Williams, Julia M, Hollander, David A
Publicado em 2014

Demonstration of an online tool to assist managed care formulary evidence-based decision making: meta-analysis of topical prostaglandin analog efficacy

Por Kymes, Steven M, Burk, Caroline, Feinman, Todd, Williams, Julia M, Hollander, David A
Publicado em 2011

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

Por Fechtner, Robert D, Harasymowycz, Paul, Nixon, Donald R, Vold, Steven D, Zaman, Fiaz, Williams, Julia M, Hollander, David A
Publicado em 2011

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Por McLaurin, Eugene B., Marsico, Nicholas P., Ackerman, Stacey L., Ciolino, Joseph B., Williams, Julia M., Villanueva, Linda, Hollander, David A.
Publicado em 2014

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

Por Ciolino, Joseph B, McLaurin, Eugene B, Marsico, Nicholas P, Ackerman, Stacey L, Williams, Julia M, Villanueva, Linda, Hollander, David A
Publicado no Clin Ophthalmol (2015)